TherapeuticsMD Inc (TXMD)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
23,727,400
EV to revenue ratio (TTM)
6.54
EV to ebitda
14.81
Financial Performance
Revenue (TTM)
3,270,000
Gross profit (TTM)
3,270,000
EBITDA
-1,369,000
Profitability
Operating margin (TTM)
-32.20%
Profit margin
-6.64%
Return on assets (TTM)
-2.88%
Return on equity (TTM)
-1.08%
Per Share Metrics
Revenue per share (TTM)
0.28
EPS
-0.03
Diluted EPS (TTM)
-0.03
Book value
2.33
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
2.326
PEG ratio
-0.73
Price to sales ratio (TTM)
7.26
Price to book ratio (TTM)
0.921
Growth
Quarterly earnings growth (YoY)
-8.70%
Quarterly revenue growth (YoY)
-80.60%
Analyst Sentiment
Strong buy
Buy
Hold
Sell
Strong sell
Risk & Volatility
Beta
0.647